Royalty Pharma(RPRX) - 2025 Q1 - Quarterly Results

Exhibit 99.1 ROYALTY PHARMA REPORTS FIRST QUARTER 2025 RESULTS NEW YORK, NY, May 8th, 2025 - Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the first quarter of 2025 and raised full year 2025 guidance for Portfolio Receipts. "Our business momentum continued in the first quarter of 2025 as we delivered double-digit growth in Portfolio Receipts and raised our financial guidance," said Pablo Legorreta, Royalty Pharma's founder and Chief Executive Officer. "Guided by our dynamic capital ...